Article
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Lupin launches loteprednol etabonate ophthalmic suspension, 0.5%, in the United States
3 Things You Should Know About Interventional Glaucoma Comanagement
Children with ADHD may be less likely to develop myopia, study suggests
Patient-Centered Treatment Strategies in the Management of nAMD and DME
AAVantgarde Bio receives IND clearance for AAVB-039
FDA accepts for review Aldeyra Therapeutics’ resubmitted New Drug Application for reproxalap